Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2002
12/19/2002WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
12/19/2002US20020193599 Dihydropyridines and new uses thereof
12/19/2002US20020193598 7-(trialkylsilylalkyl)-camptothecin of given formula by cyclizing a 4-hydroxy-6-halo,7-(trialkylsilylalkyl)-3,4,7,8-tetrahydro-1h-pyrano(3,4 -c)pyridin-3,8-dione with an aryl isonitrile
12/19/2002US20020193589 Mercaptoacetylamide derivatives, a process for their preparation and their use
12/19/2002US20020193410 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
12/19/2002US20020193407 Modulators of CCR5 chemokine receptor activity
12/19/2002US20020193405 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
12/19/2002US20020193400 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
12/19/2002US20020193398 For therapy and prophylaxis of blood coagulation and cardiovascular disorders
12/19/2002US20020193396 Sulfonamido ether substituted imidazoquinolines
12/19/2002US20020193388 Pharmaceutically active compounds
12/19/2002US20020193377 Quinazolines as MMP-13 inhibitors
12/19/2002US20020193376 Administering compounds containing fused, 6-, 5-membered bicyclic heteroaromatic rings containing nitrogen as one of the two bridging atoms for decreasing intraocular pressure in an animals including humans
12/19/2002US20020193364 For therapy of central nervous system (CNS) diseases
12/19/2002US20020193360 For enhancing cognition or in the treatment of diseases of cognitive dysfunction including but not limited to Alzheimer's Disease (AD), mild cognitive impairment, age-related cognitive decline, vascular dementia, Parkinson's disease
12/19/2002CA2450315A1 Dopamine receptor ligands and therapeutic methods based thereon
12/19/2002CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002CA2449544A1 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/19/2002CA2445467A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
12/18/2002EP1266896A1 Linear ou cyclic ureas, process for their preparation and pharmaceutical compositions containing them
12/18/2002EP1265898A2 1,8-NAPHTHALIMIDE IMIDAZO 4,5,1- i de /i ]ACRIDONES WITH ANTI-TUMOR ACTIVITY
12/18/2002EP1265897A1 Non-amidine containing protease inhibitors
12/18/2002EP1265896A1 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
12/18/2002EP1265895A1 4-oxo-1,4-dihydro 1,8]naphthyridine-3-carboxamides as antiviral agents
12/18/2002EP1265870A1 New ccr5 modulators: benzimidazoles or benzotriazoles
12/18/2002EP1149096B1 Tricyclic pyridine n-oxides vasopressin agonists
12/18/2002EP1104420B1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors
12/18/2002EP1086101B1 Beta-carboline compounds
12/18/2002EP1079833A4 Cocaine receptor binding ligands
12/18/2002EP1025101B1 Naphtho-imidazo 1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders
12/18/2002EP0880526B1 Heterocycle-condensed morphinoid derivatives (ii)
12/18/2002EP0778844B1 Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes
12/18/2002CN1385429A High-tension condensed ring nicotine analogue, preparation process and use thereof
12/18/2002CN1385228A Process for preparing matrine water aque and powder agent by CO2 super critical extraction technology
12/17/2002US6495688 Used as corticotropin-releasing factor (crf) antagonists, in therapy and diagnosis of stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety
12/17/2002US6495686 Therapy for psychological disorders
12/17/2002US6495581 Drug for treating diabetes mellitus, hyperlipemia, impaired glucose tolerance, arterial sclerosis and improving insulin resistance, inflammatory disease
12/17/2002US6495560 10,11-dihydro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1 -ethoxy)-5h-dibenzo(a,d)cycloheptene-10-acetic acid; treatment of osteoporosis
12/17/2002US6495559 For therapy of obesity
12/17/2002US6495549 1-heteroaryl-piperidine derivatives; moderating neuronal degeneration; promoting neuronal regeneration and outgrowth; treatog neurological disorders arising from neurodegenerative diseases or other disorders involving nerve damage
12/17/2002US6495543 Treating or preventing melatoninergic disorders
12/17/2002US6495542 Such as 2-methoxy-n-(2-methyl-1h-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl-benzam ide; hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome
12/17/2002US6495541 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/17/2002CA2203389C Bicyclic heterocyclic compounds for the treatment of impotence
12/16/2002WO2004055020A1 Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones
12/12/2002WO2002099388A2 Benzodiazepine bradykinin antagonists
12/12/2002WO2002098877A1 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives
12/12/2002WO2002098876A1 Cak inhibitors and uses thereof
12/12/2002WO2002098875A1 Carboline derivatives as pde-5 inhibitors
12/12/2002WO2002098860A1 Novel fused indazoles and indoles and their use for the treatment of glaucoma
12/12/2002WO2002098428A1 Tetracyclic compounds as pde5-inhibitors
12/12/2002WO2002098363A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
12/12/2002WO2002076982A3 Non-nucleoside reverse transcriptase inhibitors
12/12/2002WO2002064591A3 Carboline derivatives
12/12/2002WO2002064080A3 Matrix metalloproteinase inhibitors
12/12/2002US20020188136 Pesticides and herbicides
12/12/2002US20020188128 Substituted imidazo[1,2-A] pyridine derivatives
12/12/2002US20020188127 Process for preparing imidazoquinolinamines
12/12/2002US20020188124 Novel spiro compounds
12/12/2002US20020188004 Heterocycle carboxamides as antiviral agents
12/12/2002US20020188001 Novel crystalline forms of an integrin receptor antagonist
12/12/2002US20020188000 Imidazo-pyridine derivatives as ligands for gaba receptors
12/12/2002US20020187999 Anti-inflammatory uses of manzamines
12/12/2002US20020187981 Heterocyclic amines having central nervous system activity
12/12/2002US20020187978 4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
12/12/2002CA2449843A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use, and processes for preparing them
12/12/2002CA2447156A1 Novel fused indazoles and indoles and their use for the treatment of glaucoma
12/12/2002CA2445460A1 Carboline derivatives as pde-5 inhibitors
12/11/2002WO2001083471A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/11/2002EP1264832A1 Alkaloid halide salts of swainsonine and methods of use
12/11/2002EP1264826A1 Novel imidazoline compounds
12/11/2002EP1263760A1 Novel compounds
12/11/2002EP1263759A2 Azaindoles
12/11/2002EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002EP1263726A1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa
12/11/2002EP1263725A1 Novel compounds
12/11/2002EP1263724A1 Novel compounds
12/11/2002EP1100805B1 Medicine nitrate salts
12/11/2002EP1095025B1 Benzimidazoles, production thereof and use thereof as medicaments
12/11/2002EP0989129B1 Pyrazolopyridylpyridazinone derivatives and process for the preparation thereof
12/11/2002EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/11/2002EP0793498B1 Bicyclic heterocyclic compounds for the treatment of impotence
12/11/2002EP0752813B1 Inhibitors of metazoan parasite proteases
12/11/2002EP0662958B1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers
12/11/2002EP0624155B2 Carbamates and plant-protecting agents containing them
12/11/2002CN1384746A 单位剂量形式 Unit dosage forms
12/11/2002CN1384104A Usage, kit and composition of pyrrole derivative
12/11/2002CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative
12/11/2002CN1095841C 化合物 Compound
12/11/2002CA2411165A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/10/2002US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002US6492520 Substituted pyrido-or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
12/10/2002US6492409 Such as 5-(1-(3-aminopropyl)-3-indolyl)-1-(3-indolyl)-1,3-dihydroimidazol-2-one; protein kinase c inhibitors; high solubility; reduced color; treating inflammatory and/or immunological disorders
12/10/2002US6492406 Pharmaceutically active compounds
12/10/2002US6492400 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/10/2002US6492393 Compounds useful as anti-inflammatory agents
12/10/2002US6492391 Treating bacterial infection